Desh Rakshak Aushdhalaya logo

Desh Rakshak Aushdhalaya PE ratio history and valuation

BSE: 531521Pharmaceuticals & BiotechnologySmall Cap

Desh Rakshak Aushdhalaya Ltd. · Face value ₹10
Last close ₹26.90₹0.00 (0.00%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹26.90.

23 Oct: open ₹26.90, high ₹26.90, low ₹26.90

52-week range of traded prices to 23 Oct 2026
₹22.45Low, 6 May 2026₹56.58High, 23 Oct 2025
Market cap
₹15 Cr4,278th largest listed
P/E
27.77
P/B
1.15
Dividend yield
Nonein the last 12 months
ROE
4.7%
ROCE
5.8%
Debt to equity
0.21
Volume, BSE
100

Desh Rakshak Aushdhalaya's P/E, price to book, price to sales, EV to EBITDA, dividend yield and earnings yield on 23 Oct 2026. Each gets a history once a year of trading is on record. The P/E is the market cap over the profit of the twelve months to Jun 2026.

Desh Rakshak Aushdhalaya PE ratio and valuation against its own history

  • Price to earnings27.77today
  • Price to book1.15today
  • Price to sales2.31today
  • EV to EBITDA13.00today
  • Dividend yield0.00%today
  • Earnings yield3.60%today

Dividend yield is in per cent. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.

How each ratio is worked out, with today's figures
  • Price to earnings =Market cap÷Net profit, last twelve months₹0.55 Cr
  • Price to book =Market cap÷Net worth₹13 Cr
  • Price to sales =Market cap÷Revenue, last twelve months₹6.63 Cr
  • Enterprise value =Market cap+Borrowings₹2.80 Cr−Cash₹0.15 Cr
  • EV to EBITDA =Enterprise value÷Operating profit, last twelve months₹1.38 Cr
  • Market cap =Close×Shares in issue56,98,324at 30 Sep 2026

Standalone accounts, the twelve months to Jun 2026, balance sheet at Mar 2026, ₹ crore.Desh Rakshak Aushdhalaya financials ›

Desh Rakshak Aushdhalaya valuation at each year end

On the last trading day of each March, the month the company's year ends.

RatioMar 2017Mar 2018Mar 2019Mar 2021Mar 2025Mar 2026
Market cap (₹ crore)3.33.01.81.813.415.4
Price to earnings14.4No full year4.75.525.624.5
Price to book0.5No recent balance sheet0.20.21.41.2
Price to sales0.6No full year0.30.32.01.9
EV to EBITDAOperating profit not statedNo full year3.76.812.69.9
Dividend yield0.00%0.00%0.00%0.00%0.00%0.00%
Earnings yield6.9%No full year21.2%18.2%3.9%4.1%
A ratio that does not exist on the day says why in its cell.

Desh Rakshak Aushdhalaya market cap, ten years

The last trading day of each month.

Market cap, ₹ crore

  • Market cap
₹39 Cr₹1.74 Cr₹15 CrNov 16Aug 18Jul 20Oct 22Jun 24Mar 25Nov 25Oct 26

Earnings per share, book value and enterprise value

From the close on 23 Oct 2026, with the last twelve months' results.

Enterprise value
₹18 Cr
Earnings per share
₹0.97
Book value per share
₹23.32
Dividends, last 12 months
None
Public's market cap
₹7.66 Cr

Against Pharmaceuticals

215 listed companies in Pharmaceuticals, each priced on its last trading day; Desh Rakshak Aushdhalaya is 205th among them by market cap. Each median leaves out Desh Rakshak Aushdhalaya itself and takes the other companies that have the figure.

Industry median P/E
28.1Across 156 other companies
Industry median P/B
3.0Across 190 other companies
Industry median EV/EBITDA
19.2Across 143 other companies
Industry median dividend yield
0.49%Across 89 other companies
Company
Colinz Laboratories logoColinz LaboratoriesCOLINZ176.221.7327.70.00%
Span Divergent logoSpan DivergentSDL17–1.11–0.00%
Mono PharmacareMONOPHARMA1646.390.52–0.00%
Star Source Multi Trade logoStar Source Multi TradeSTARSOURCE16–12.64–0.00%
Desh Rakshak Aushdhalaya logoDesh Rakshak AushdhalayaDESHRAK1527.771.1513.00.00%
Venmax Drugs and Pharmaceuticals logoVenmax Drugs and PharmaceuticalsVENMAX15–––0.00%
Beryl Drugs logoBeryl DrugsBERLDRG1320.991.338.40.00%
Unjha Formulations logoUnjha FormulationsUNJHAFOR1225.643.1514.20.00%
Ortin Global logoOrtin GlobalORTINGLOBE10–8.16–0.00%
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.